Combination Chemotx in Treating Children or Adolescents With Newly Diagnosed Stg III or Stg IV Lymphoblastic Lymphoma
Status:
Completed
Trial end date:
2015-03-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cells from dividing
so they stop growing or die. It is not yet known which regimen of combination chemotherapy is
most effective for lymphoblastic lymphoma.
PURPOSE: This randomized phase III trial is studying different regimens of combination
chemotherapy to compare how well they work in treating children or adolescents with newly
diagnosed stage III or stage IV lymphoblastic lymphoma.